tiprankstipranks
Advertisement
Advertisement

Moolec Science Wins Conditional Nasdaq Listing Extension After Reverse Stock Split

Story Highlights
  • Moolec Science secured conditional continued listing on Nasdaq after regaining minimum bid price compliance in January 2026.
  • The company must meet equity, reporting, and disclosure milestones through May 13, 2026 to maintain its Nasdaq Capital Market listing.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Moolec Science Wins Conditional Nasdaq Listing Extension After Reverse Stock Split

Claim 30% Off TipRanks

Moolec Science ( (MLEC) ) has shared an update.

On January 30, 2026, Moolec Science announced that a Nasdaq Hearings Panel has granted the company continued listing on the Nasdaq Stock Market, after Moolec regained compliance with the minimum bid price requirement on January 16, 2026, following a reverse stock split that became effective on January 5, 2026, and filed its delayed annual report for the fiscal year ended June 30, 2025 on December 29, 2025. The panel’s decision keeps Moolec under Nasdaq oversight through May 13, 2026 and is contingent on the company meeting several conditions, including providing updates on derecognition proceedings by the end of February 2026, submitting updated pro forma financial information by the end of March 2026, publicly disclosing actions taken to meet equity and listing standards by May 13, 2026, and proving full compliance with all Nasdaq Capital Market continued listing requirements by that date, a framework that underscores both the company’s precarious past compliance status and the critical importance for shareholders of Moolec successfully executing its financial and strategic plans to preserve its U.S. listing.

The most recent analyst rating on (MLEC) stock is a Sell with a $7.00 price target. To see the full list of analyst forecasts on Moolec Science stock, see the MLEC Stock Forecast page.

Spark’s Take on MLEC Stock

According to Spark, TipRanks’ AI Analyst, MLEC is a Neutral.

The score is primarily held down by weak financial performance (large losses, cash burn, negative equity and higher debt) and bearish technicals (below key moving averages with negative MACD). Valuation provides limited offset because the negative P/E is driven by losses and there is no dividend support.

To see Spark’s full report on MLEC stock, click here.

More about Moolec Science

Moolec Science S.A. is a science-based food ingredient company that develops scalable protein solutions for the global food market, focusing on innovative protein technologies to supply alternative and functional ingredients to the food industry.

Average Trading Volume: 315,174

Technical Sentiment Signal: Sell

Current Market Cap: $4.81M

For an in-depth examination of MLEC stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1